Sepracor’s Insomnia Drug Enters Europe with GSK Deal

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 88 (Table of Contents)

Published: 7 Oct-2007

DOI: 10.3833/pdr.v2007.i88.279     ISSN: 1756-7874

Section: Licensing



Sepracor out-licensed the commercialization rights for insomnia product Lunivia® to GlaxoSmithKline (GSK) which will market the product worldwide excluding US, Canada, Mexico and Japan...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details